BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31983743)

  • 1. Outcome of interventional treatment modalities for retinoblastoma: Experience at a tertiary care centre in Pakistan.
    Mian LS; Aqil A; Abid K; Moin M
    J Pak Med Assoc; 2019 Jul; 69(7):1039-1043. PubMed ID: 31983743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.
    Abramson DH; Fabius AW; Francis JH; Marr BP; Dunkel IJ; Brodie SE; Escuder A; Gobin YP
    Ophthalmic Genet; 2017; 38(1):16-21. PubMed ID: 28095092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review.
    Abramson DH; Marr BP; Brodie SE; Dunkel I; Palioura S; Gobin YP
    PLoS One; 2012; 7(4):e34120. PubMed ID: 22545080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Ophthalmic Artery Chemotherapy with Melphalan in the Management of Unilateral Retinoblastoma: A Prospective Study.
    Lumbroso-Le Rouic L; Blanc R; Saint Martin C; Savignoni A; Brisse HJ; Pierrat N; Lévy-Gabriel C; Matet A; Doz F; Aerts I; Cassoux N
    Ophthalmol Retina; 2021 Aug; 5(8):e30-e37. PubMed ID: 34000459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma.
    Abramson DH; Catalanotti F; Brodie SE; Kellick MG; Francis JH
    Ophthalmic Genet; 2018 Jun; 39(3):353-356. PubMed ID: 29513055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of primarily treated group D retinoblastoma.
    Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma.
    Abramson DH; Daniels AB; Marr BP; Francis JH; Brodie SE; Dunkel IJ; Gobin YP
    PLoS One; 2016; 11(1):e0146582. PubMed ID: 26756643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indocyanine green enhanced transpupillary thermotherapy in combination with ophthalmic artery chemosurgery for retinoblastoma.
    Francis JH; Abramson DH; Brodie SE; Marr BP
    Br J Ophthalmol; 2013 Feb; 97(2):164-8. PubMed ID: 23143908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
    Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
    J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ophthalmic artery chemosurgery for the management of retinoblastoma in eyes with extensive (>50%) retinal detachment.
    Palioura S; Gobin YP; Brodie SE; Marr BP; Dunkel IJ; Abramson DH
    Pediatr Blood Cancer; 2012 Nov; 59(5):859-64. PubMed ID: 22492689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
    Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH
    JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
    Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
    J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.
    Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ
    Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Globe salvage treatment in group D and group E retinoblastoma.
    Hussain AK; Rahul RA; Carlos RL; Francisco ZM; María GL; Flavia P; Chiara B; Davide B
    Rom J Ophthalmol; 2021; 65(1):20-24. PubMed ID: 33817429
    [No Abstract]   [Full Text] [Related]  

  • 15. Modern treatment of retinoblastoma: A 2020 review.
    Ancona-Lezama D; Dalvin LA; Shields CL
    Indian J Ophthalmol; 2020 Nov; 68(11):2356-2365. PubMed ID: 33120616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
    Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
    Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy.
    Francis JH; Roosipu N; Levin AM; Brodie SE; Dunkel IJ; Gobin YP; Abramson DH
    Neoplasia; 2018 Aug; 20(8):757-763. PubMed ID: 29940303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
    Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Retinoblastoma in 2015: Agreement and Disagreement.
    Abramson DH; Shields CL; Munier FL; Chantada GL
    JAMA Ophthalmol; 2015 Nov; 133(11):1341-7. PubMed ID: 26378747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
    Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
    J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.